TRPM7 and myalgic encephalomeyelitis/chronic fatigue syndrome: Further characterisation of TRPM7 at the biochemical, cellular, and organismal level is therefore indicated to improve clinical outcomes for ME/CFS patients, as a sound theoretical rationale for this endeavour exists.